Cargando…

Favourable effect of a ‘second hit’ after 13 weeks in early RA non-responders: the Amsterdam COBRA treat-to-target randomized trial

OBJECTIVE: The aim of this study was to investigate the effect of treat-to-target combination therapy with intensification at 13 weeks in early RA. METHODS: Early RA patients were classified as being at high or low risk of worsening RA based on disease activity and prognostic factors. High-risk pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hartman, Linda, Rasch, Linda A, Turk, Samina A, ter Wee, Marieke M, Kerstens, Pit J S M, van der Laken, Conny J, Nurmohamed, Michael T, van Schaardenburg, Dirkjan, van Tuyl, Lilian H D, Voskuyl, Alexandre E, Boers, Maarten, Lems, Willem F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234185/ https://www.ncbi.nlm.nih.gov/pubmed/36205538 http://dx.doi.org/10.1093/rheumatology/keac582

Ejemplares similares

A non-inferiority trial of an attenuated combination strategy (‘COBRA-light’) compared to the original COBRA strategy: clinical results after 26 weeks
por: den Uyl, Debby, et al.
Publicado: (2014)

Cost-utility of COBRA-light versus COBRA therapy in patients with early rheumatoid arthritis: the COBRA-light trial
por: ter Wee, Marieke M, et al.
Publicado: (2017)

Pain, sleep and emotional well-being explain the lack of agreement between physician- and patient-perceived remission in early rheumatoid arthritis
por: Turk, Samina A., et al.
Publicado: (2018)

Early prediction of treatment response in rheumatoid arthritis by quantitative macrophage PET
por: Verweij, Nicki, et al.
Publicado: (2022)

An unfavorable body composition is common in early arthritis patients: A case control study
por: Turk, Samina A., et al.
Publicado: (2018)

Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high-dose prednisolone, in early rheumatoid arthritis patients: the COBRA-light trial
por: Lucassen, M. J. J., et al.
Publicado: (2021)

Subclinical synovitis detected by macrophage PET, but not MRI, is related to short-term flare of clinical disease activity in early RA patients: an exploratory study
por: Gent, Yoony Y. J., et al.
Publicado: (2015)

Measurement of stiffness in patients with rheumatoid arthritis in low disease activity or remission: a systematic review
por: van Tuyl, Lilian HD, et al.
Publicado: (2014)

The type I interferon signature in leukocyte subsets from peripheral blood of patients with early arthritis: a major contribution by granulocytes
por: de Jong, Tamarah D., et al.
Publicado: (2016)

The value of ultrasonography in predicting arthritis in auto-antibody positive arthralgia patients: a prospective cohort study
por: van de Stadt, Lotte A, et al.
Publicado: (2010)

Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial
por: van Boheemen, Laurette, et al.
Publicado: (2021)

Smartphone‐Assisted Patient‐Initiated Care Versus Usual Care in Patients With Rheumatoid Arthritis and Low Disease Activity: A Randomized Controlled Trial
por: Seppen, Bart, et al.
Publicado: (2022)

The value of joint ultrasonography in predicting arthritis in seropositive patients with arthralgia: a prospective cohort study
por: van Beers-Tas, Marian H., et al.
Publicado: (2018)

Arterial wall inflammation is increased in rheumatoid arthritis compared with osteoarthritis, as a marker of early atherosclerosis
por: Agca, Rabia, et al.
Publicado: (2021)

Confounding by Indication Probably Distorts the Relationship between Steroid Use and Cardiovascular Disease in Rheumatoid Arthritis: Results from a Prospective Cohort Study
por: van Sijl, Alper M., et al.
Publicado: (2014)

Antirheumatic drugs for cardiovascular disease prevention: the case for colchicine
por: Lems, Willem, et al.
Publicado: (2021)

An intervention program with the aim to improve and maintain work productivity for workers with rheumatoid arthritis: design of a randomized controlled trial and cost-effectiveness study
por: Vilsteren, Myrthe van, et al.
Publicado: (2012)

A prospective cohort study of 14-3-3η in ACPA and/or RF-positive patients with arthralgia
por: van Beers-Tas, Marian H., et al.
Publicado: (2016)

(Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis
por: den Uyl, Debby, et al.
Publicado: (2011)

Effect of prednisone on type I interferon signature in rheumatoid arthritis: consequences for response prediction to rituximab
por: de Jong, Tamarah D, et al.
Publicado: (2015)

Dietary Interventions for Gout and Effect on Cardiovascular Risk Factors: A Systematic Review
por: Vedder, Daisy, et al.
Publicado: (2019)

Productivity at work and quality of life in patients with rheumatoid arthritis
por: van Vilsteren, Myrthe, et al.
Publicado: (2015)

Cardiovascular risk in persons at risk of developing rheumatoid arthritis
por: van Boheemen, Laurette, et al.
Publicado: (2020)

The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients
por: Raterman, Hennie G, et al.
Publicado: (2012)

The Lore of Amsterdam /
por: Heyden, A. A. M. Van der

Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases
por: de Jong, Tamarah D., et al.
Publicado: (2016)

Content validity of the Dutch Rheumatoid Arthritis Impact of Disease (RAID) score: results of focus group discussions in established rheumatoid arthritis patients and comparison with the International Classification of Functioning, Disability and Health core set for rheumatoid arthritis
por: ter Wee, Marieke M., et al.
Publicado: (2016)

Variability in quantitative analysis of atherosclerotic plaque inflammation using (18)F-FDG PET/CT
por: Lensen, Karel-Jan D. F., et al.
Publicado: (2017)

Rijksmuseum de Amsterdam
por: Van der Waals, J. C.
Publicado: (1968)

Development of prediction models to select older RA patients with comorbidities for treatment with chronic low-dose glucocorticoids
por: Hartman, Linda, et al.
Publicado: (2022)

Repair of joint damage in patients with rheumatoid arthritis does not relate to previous suppression of inflammation: a subanalysis after 8 years treat-to-target in the BeSt-trial
por: van der Pol, Joy Ardjuna, et al.
Publicado: (2023)

Dynamics of the Type I Interferon Response During Immunosuppressive Therapy in Rheumatoid Arthritis
por: de Jong, Tamarah D., et al.
Publicado: (2019)

Outcome measures for adherence data from a medication event monitoring system: A literature review
por: Hartman, Linda, et al.
Publicado: (2018)

A Smartphone App for Self-Monitoring of Rheumatoid Arthritis Disease Activity to Assist Patient-Initiated Care: Protocol for a Randomized Controlled Trial
por: Seppen, Bart F, et al.
Publicado: (2020)

One-year effects of glucocorticoids on bone density: a meta-analysis in cohorts on high and low-dose therapy
por: Lems, Willem F, et al.
Publicado: (2016)

Cobra /
por: Sarduy, Severo
Publicado: (1972)

18F-Fluorodeoxyglucose Positron Emission Tomography in Elderly Patients with an Elevated Erythrocyte Sedimentation Rate of Unknown Origin
por: Lensen, Karel-Jan D. F., et al.
Publicado: (2013)

Aggressive therapy in patients with early arthritis results in similar outcome compared with conventional care: the STREAM randomized trial
por: van Eijk, Izhar C., et al.
Publicado: (2012)

[(18)F]Fluoride PET provides distinct information on disease activity in ankylosing spondylitis as compared to MRI and conventional radiography
por: de Jongh, Jerney, et al.
Publicado: (2022)

Determinants of pain and activity limitations in foot osteoarthritis: An exploratory cross-sectional study in the Amsterdam-foot cohort
por: Ryman, V.F.M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jonnqdvqben6jv1rcjk8kbf1qf